NCT03267563

Brief Summary

Postpartum depression (PPD) is common and can have lasting consequences for mother and child. ROSE is an intervention to prevent PPD, delivered during pregnancy in outpatient prenatal settings. ROSE has been found to significantly reduce cases of PPD in multiple randomized trials in community prenatal settings with racially and ethnically diverse low-income pregnant women. Requests for ROSE training and recent policy changes supporting payment for comprehensive perinatal services to underserved populations suggest a context ripe for embedding ROSE in prenatal clinics long-term. Given the need for return on investment studies about sustainment efforts, we propose a Sequential Multiple Assignment Randomized (SMART) Trial of the effectiveness and cost-effectiveness of a stepwise approach to sustainment of ROSE in 90 outpatient clinics providing prenatal care to pregnant women on public assistance in 6 U.S. states. In Year 1, all clinics will receive enhanced implementation as usual (EIAU; initial training + tools for sustainment). At the first time at which a clinic is determined to be at risk for failure to sustain (i.e., at 3, 6, 9, 12, 15 months), that clinic will be randomized to receive either: (1) no additional implementation support (i.e., EIAU only), or (2) low-intensity coaching and feedback (LICF). If clinics receiving LICF are still found to be at risk at subsequent assessments, they will be randomized to either (1) EIAU + LICF only, or (2) high-intensity coaching and feedback (HICF). Additional study follow-up interviews will occur at 18, 24, and 30 months, but no implementation intervention will occur after 18 months. Outcomes include: 1. Sustainment of core program elements at each time point and total length of time ROSE services were provided and were provided with at least moderate fidelity. 2. Health impact (PPD rates over time at each clinic) and reach. 3. ROI (costs, cost-offsets, and cost-effectiveness) of each sustainment step. Hypothesized mechanisms include sustainment of clinical and organizational capacity to deliver core elements, and engagement/ownership. The study will also examine predictors, tailoring variables, and implementation processes to determine which kinds of clinics need which level of sustainment support and when. To our knowledge, this study will be the first randomized trial evaluating the ROI of a stepped approach to sustainment, a critical unanswered question in implementation science.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 30, 2017

Completed
10 months until next milestone

Study Start

First participant enrolled

June 12, 2018

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
2.3 years until next milestone

Results Posted

Study results publicly available

April 15, 2026

Completed
Last Updated

April 15, 2026

Status Verified

March 1, 2026

Enrollment Period

5.6 years

First QC Date

August 28, 2017

Results QC Date

July 17, 2025

Last Update Submit

March 26, 2026

Conditions

Keywords

preventionimplementationsustainmentperinatalpregnancypostpartum

Outcome Measures

Primary Outcomes (3)

  • Proportion Sustainment of Core Program Elements

    Proportion sustainment of ROSE's core program elements, assessed using the ROSE Session-by-Session Adherence Scale, was defined as the mean proportion of core elements delivered that should have been delivered at each ROSE session over the time period (zero if no sessions were completed). Potential range is 0 to 1, higher score reflects better outcome.

    Average over months 3, 6, 9, 12, 15, 18, 24, and 30 after baseline

  • Number of Months of Sustained ROSE Delivery

    Number of months when ROSE was delivered was tracked using calendar method. Potential range is 0 to 30 months, higher score reflects better outcome.

    Summary of total number of months over 30 month study period.

  • Number of Months of Sustained ROSE Delivery With Fidelity

    Number of months when ROSE was delivered with fidelity was tracked using calendar method. Potential range is 0 to 30 months, higher score reflects better outcome.

    Summary of total number of months over 30 month study period.

Secondary Outcomes (2)

  • Annualized Percent of Pregnant People Attending at Least One ROSE Session Over 30 Months

    Summary over 30 month study period.

  • Annualized Percent of Pregnant People Attending at Least Three ROSE Sessions (of Five) Over 30 Months

    Summary over 30 month study period.

Study Arms (3)

Enhanced implementation as usual (EIAU)

EXPERIMENTAL

EIAU: Enhanced implementation as usual consists of initial training and problem-solving plus planning for sustainment.

Behavioral: EIAUBehavioral: LICFBehavioral: HICF

Low-intensity coaching and feedback (LICF)

EXPERIMENTAL

Low-intensity (every 3 months) coaching and feedback (LICF): Enhanced implementation plus low intensity will have received initial training and problem-solving plus planning for sustainment and after that every 3 months will receive one clinical and one operational telephone "booster" meeting.

Behavioral: LICFBehavioral: HICF

High-intensity coaching and feedback (HICF)

EXPERIMENTAL

High-intensity (every month) coaching and feedback (HICF): Enhanced implementation plus high intensity will have received initial training and problem-solving plus planning for sustainment and after that every month will receive one clinical and one operational telephone "booster" meeting.

Behavioral: HICF

Interventions

EIAUBEHAVIORAL

Enhanced implementation as usual consists of initial training and problem-solving plus planning for sustainment,

Enhanced implementation as usual (EIAU)
LICFBEHAVIORAL

Enhanced implementation plus low intensity will have received initial training and problem-solving plus planning for sustainment and after that every 3 months will receive one clinical and one operational telephone "booster" meeting.

Enhanced implementation as usual (EIAU)Low-intensity coaching and feedback (LICF)
HICFBEHAVIORAL

Enhanced implementation plus high intensity will receive will receive everything that the clinics in LICF receive, but at a higher intensity.

Enhanced implementation as usual (EIAU)High-intensity coaching and feedback (HICF)Low-intensity coaching and feedback (LICF)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • outpatient,
  • provide prenatal services,
  • estimate at least 30% of their pregnant patients received some kind of public assistance (such as federal or state cash assistance, food stamps, subsidized housing, and/or health insurance such as Medicaid),
  • have at least 3 new pregnant people per month on average (i.e., enough patient flow to run ROSE), and
  • age 18 or older
  • someone chosen by the agency to respond to quarterly survey questions about clinical delivery of ROSE (the "clinical respondent");
  • someone chosen by the agency to respond to quarterly surveys about operational (billing, scheduling) aspects of ROSE delivery (the "operational respondent," which could be the same or a different person than the "clinical respondent");
  • all ROSE facilitators for the agency (who completed self-rated ROSE adherence forms).

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michigan State University

Flint, Michigan, 48502, United States

Location

Related Publications (2)

  • Johnson JE, Wiltsey-Stirman S, Sikorskii A, Miller T, Poleshuck E, Simas TAM, Carravallah L, Miller R, Zlotnick C. Outcomes of the ROSE Sustainment (ROSES) Study, a sequential multiple assignment randomized implementation trial to determine the minimum necessary intervention to sustain a postpartum depression prevention program in agencies serving low-income pregnant people. Implement Sci. 2025 Feb 10;20(1):9. doi: 10.1186/s13012-025-01420-z.

  • Johnson JE, Wiltsey-Stirman S, Sikorskii A, Miller T, King A, Blume JL, Pham X, Moore Simas TA, Poleshuck E, Weinberg R, Zlotnick C. Protocol for the ROSE sustainment (ROSES) study, a sequential multiple assignment randomized trial to determine the minimum necessary intervention to maintain a postpartum depression prevention program in prenatal clinics serving low-income women. Implement Sci. 2018 Aug 22;13(1):115. doi: 10.1186/s13012-018-0807-9.

MeSH Terms

Conditions

Depression, Postpartum

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental Disorders

Limitations and Caveats

The study period included COVID-19 pandemic with a temporary pause in randomizations.

Results Point of Contact

Title
Dr. Jennifer Johnson
Organization
Michigan State University

Study Officials

  • Jennifer E Johnson, Ph.D.

    Michigan State University

    PRINCIPAL INVESTIGATOR
  • Raven Miller, M.A.

    Michigan State University

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Sequential, multiple assignment, randomized trial (SMART) design. Three interventions were sequenced.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
C. S. Mott Endowed Professor of Public Health, Professor of OBGYN, Professor of Psychiatry and Behavioral Medicine

Study Record Dates

First Submitted

August 28, 2017

First Posted

August 30, 2017

Study Start

June 12, 2018

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

April 15, 2026

Results First Posted

April 15, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

After data have been collected and study results published, de-identified data will be made available to other qualified researchers upon request, on a CD or other electronic means compatible with our systems. The request will be evaluated by the PIs to ensure that it meets reasonable standards of scientific integrity. We have use standard measures where possible in order to promote data sharing and integration into larger databases and to allow other researchers to analyze the data, including conducting meta-analyses. We will work on the data dictionary throughout the study. Data checking will occur regularly. We will submit primary results for publication by the end of the project period, and will have final de-identified datasets and data dictionaries available by CD within the required time frame.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
After publication of the main results
Access Criteria
De-identified data will be made available for scientific inquiry

Locations